Thanks for the pointer. That was interesting reading, and the original article was fairly friendly to the non-specialist.
Part of the problem is that there is "no money" in vaccines. Well there was none, until the pandemic. We'll see what happens after the pandemic. Maybe society and medicine will have a different perspective, although reading
sengsational's excellent posts about treatment options (and the money involved) give me less hope.
Back to the article. There are pointers to the studies. The important take-away is there were no significant adverse effects. The studies were also looking at other issues regarding delivery (needle or not). This was all part of the work involving the "fat blob" delivery, so I'd hardly say it was a failure. They were learning.
In summary:
- Rabies: From 2017. Safe and effective, but needle injection doesn't work effectively. [Joe: I guess they fixed this?]
- Influenza: direct quote - "The first mRNA vaccines against H10N8 and H7N9 influenza viruses were well tolerated and elicited robust humoral immune responses." [Joe: but is there money in it, considering the now well known issues with freezers, etc.]
- Zika: no results. This study was to conclude about now, with the main study time being in 2020. It looks like it might have been paused or aborted because, uh, "something else" came up. Or maybe not. Could still just be gathering results.